stars 1 stars 2 stars 3

Pendulum Therapeutics is the leading innovator in microbiome science, delivering research based probiotic formulations to support metabolic health. The company leverages cutting-edge research and strong intellectual property to bring effective, science-backed solutions to consumers worldwide. Pendulum Akkermansia was the first novel species to be brought to the probiotics market in more than 50 years. The first and only probiotic in the world clinically proven to lower A1C and blood glucose in people with type 2 diabetes, Akkermansia stimulates natural GLP-1 production.

Pendulum Therapeutics Questions

The Pendulum Therapeutics annual revenue was $8.8 million in 2026.

Andrey Reznik is the CFO of Pendulum Therapeutics.

93 people are employed at Pendulum Therapeutics.

Pendulum Therapeutics is based in San Francisco, California.

The NAICS codes for Pendulum Therapeutics are [32, 3254, 325, 32541].

The SIC codes for Pendulum Therapeutics are [283, 28, 2834].

Top Pendulum Therapeutics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users